InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by Carruthers R Michael, Chief Financial Officer. Officer active across 2 companies, notably Edgewise Therapeutics, Inc.. Cumulatively, 11 reports have been published. Activity tracked since 23 May 2022. The latest transaction was disclosed on 12 August 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
11 of 11 declarations
R. Michael Carruthers is the Chief Financial Officer at Edgewise Therapeutics, Inc. He is responsible for managing the company's finances, including financial planning, risk management, and financial compliance. Carruthers plays a crucial role in financial strategy and the sustainability of the organization.